We are looking for an enthusiastic and talented Front-End Software Developer to join the Open Targets team and help us build the next generation of open source and big data tools and services that support the drug discovery process.
As a key member of the Open Targets Core Team, you will work on developing and maintaining our two flagship open-source resources - the Open Targets Platform (www.targetvalidation.org) and the Genetics Portal (http://genetics.opentargets.org). Together, these two resources integrate, organise, and present vast amounts of biomedical data in order to help research scientists identify and prioritise potential therapeutic drug targets.
Open Targets is a pioneering public-private partnership between Biogen, Celgene, EMBL-EBI, GSK, Sanofi, Takeda, and the Wellcome Sanger Institute. Open Targets brings together the expertise from seven complementary institutions to generate evidence on the biological validity of therapeutic targets and provide an initial assessment of the likely effectiveness of pharmacological intervention on these targets, using genome-scale experiments and analysis. Open Targets aims to provide an R&D framework that applies to all aspects of human disease, to improve the success rate for discovering new medicines, and share its data openly in the interests of accelerating drug discovery.
You will join a fast-paced, international, startup-like environment, where the latest technologies in front-end development and data visualisation are utilised to offer our users a best-in-class experience and to influence decisions in the drug discovery area across the world.
You will work in a dynamic, collaborative team environment and will work alongside colleagues and external partners that bring a wealth of experience and a range of expertise from everything from Bioinformatics and Big Data pipelines to data visualisations, user experience, and scientific outreach.
The team is in a rapid growth phase and so we are looking for candidates with a range of experience. We want to hear from junior developers with an outstanding portfolio and passion for learning and trying new technology. And we want to hear from mid-level and senior developers with experience in building scalable software who can drive FE decisions and that want to advance their career.
The main responsibilities will include:
Additionally, we also are looking for candidates who:
You might also have
And if you bring any of the following skills or experience, that’s a plus:
Why join us
Our supportive culture encourages personal and professional development and we are committed to ensuring our employees feel valued, supported and empowered to reach their potential at work.
Surrounded by beautiful South Cambridgeshire countryside, our Campus provides employees with a relaxed atmosphere where the pursuit of scientific discovery and meaningful work, underpin every role. In addition, our employees have access to a wide range of benefits including:
What else you need to know
To apply please submit a covering letter and CV through our online system. At EMBL-EBI, we strongly believe that inclusive and diverse teams benefit from higher levels of innovation and creative thought. We encourage applications from women, LGBTQ and individuals from all nationalities. Applications are encouraged from all nationalities and this has continued after Brexit. For more information please see our website. Visa information will be discussed in more depth with applicants selected for interview.
This position is limited to a 3 year duration until 27/02/2024 max. in the first instance. The role is based in Hinxton, UK and you will be required to relocate if not based locally. There will be a relocation package including installation grant (if applicable). More info on how we are recruiting in this period is available on our page: Recruitment and Onboarding during Covid19.
Applications will close at 23:00 GMT on the date listed above. We will get back to you in the New Year regarding interviews should you be shortlisted.
Appointment will be based on merit alone.